BRENTUXIMAB VEDOTIN FOR TREATMENT IN PATIENTS WITH RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA IN A REAL WORLD SETTING: CLINICAL OUTCOMES AND IMPACT ON QUALITY OF LIFE. (17th June 2021) - Ionova, T.; Andrievskikh, M.; Amdiev, A.; Baryakh, E.; Chang, V.; Endakova, A.; Fadeeva, N.; Husainova, G.; Ivanov, V.; Kaplanov, K.; Kaverina, O.; Kiseleva, M.; et al.